|
Senores Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
3466.22 Cr.
|
P/BV
|
4.41
|
Book Value (Rs.)
|
170.71
|
|
52 Week High/Low (Rs.)
|
832/435
|
FV/ML
|
10/1
|
P/E(X)
|
59.19
|
|
Bookclosure
|
|
EPS (Rs.)
|
12.72
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 284.04 | 112.08 |
| Total Income From Operations | 284.04 | 112.08 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 70.70 | 6.93 |
| Purchase of Traded Goods | 60.76 | 55.28 |
| Increase/Decrease in Stocks | -8.21 | -1.46 |
| Employees Cost | 45.73 | 17.20 |
| Depreciation | 11.61 | 6.31 |
| Other Expenses | 44.80 | 14.92 |
| Total Expenses | 225.39 | 99.18 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 58.65 | 12.90 |
| Other Income | 7.49 | 0.86 |
| P/L Before Interest, Excpt. Items & Tax | 66.14 | 13.76 |
| Interest | 16.25 | 6.42 |
| P/L Before Exceptional Items & Tax | 49.89 | 7.34 |
| P/L Before Tax | 49.89 | 7.34 |
| Tax | 9.52 | -11.19 |
| P/L After Tax from Ordinary Activities | 40.37 | 18.53 |
| Net Profit/Loss For the Period | 40.37 | 18.53 |
| Net P/L After Minority Interest & Share Of Associates | 40.37 | 18.53 |
| | | |
| Equity Share Capital | 46.05 | 29.95 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 12.14 | 8.68 |
| Diluted EPS (Rs.) | 12.14 | 7.52 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 12.14 | 8.68 |
| Diluted EPS (Rs.) | 12.14 | 7.52 |
| | | |
| PBITOE Margin (%) | 20.64 | 11.50 |
| PBTE Margin (%) | 17.56 | 6.54 |
| PBT Margin (%) | 17.56 | 6.54 |
| PAT Margin (%) | 14.21 | 16.53 |
| PAT After MI And SOA Margin (%) | 14.21 | 16.53 |
